Elvira Yunita

Mrs. Elvira Yunita

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SWSeptelia Inawati Wanandi
Septelia Inawati Wanandi
ALAgus Limanto
Agus Limanto
EYElvira Yunita
Elvira Yunita
RSResda Akhra Syahrani
Resda Akhra Syahrani
MLMelva Louisa
Melva Louisa
SASekar Arumsari
Sekar Arumsari
Breast cancer stem cells (BCSCs) express high levels of the anti-apoptotic protein, survivin. This study aimed to discover a natural active compound with anti-cancer properties that targeted survivin in human breast cancer stem cells. From the seven examined compounds, andrographolide was selected as a lead compound through in silico molecular docking with survivin, caspase-9, and caspase-3. We found that the affinity between andrographolide and survivin is higher than that with caspase-9 and caspase-3. Human CD24-/CD44+ BCSCs were treated with andrographolide in vitro for 24 hours. The cytotoxic effect of andrographolide on BCSCs was compared to that on human mesenchymal stem cells (MSCs). The expression of survivin, caspase-9, and caspase-3 mRNA was analyzed using qRT-PCR, while Thr34-phosphorylated survivin and total survivin levels were determined using ELISA and Immunoblotting assay. Annexin-V/PI flow cytometry assays were performed to evaluate the apoptotic activity of andrographolide. Our results demonstrate that the CC50 of andrographolide in BCSCs was 0.32mM, whereas there was no cytotoxic effect in MSCs. Moreover, andrographolide decreased survivin and Thr34-phosphorylated survivin, thus inhibiting survivin activation and increasing survivin mRNA in BCSCs. The apoptotic activity of andrographolide was revealed by the increase of caspase-3 mRNA and protein, as well as the increase in both the early and late phases of apoptosis. In conclusion, andrographolide can be considered an anti-cancer compound that targets BCSCs due to its molecular interactions with survivin, caspase-9, and caspase-3, which induce apoptosis. We suggest that the binding of andrographolide to survivin is a critical aspect of the effect of andrographolide.

27 March 2021 in Herb-Medicine Journal: Terbitan Berkala Ilmiah Herbal, Kedokteran dan Kesehatan
Verified
Journal Article
Open access
PDF file
EYElvira Yunita
Elvira Yunita
Andrographolide is the main bioactive compound derived from sambiloto, Andrographis paniculata. Andrographolide compounds can potentially be used as phytopharmaca substances. Andrographolide has very broad pharmacological aspects, including anti-inflammatory, anticancer and anti-diabetic. The pharmacological aspects possessed by andrographolide are probably closely related to the chemical profile and the mechanism of action of andrographolide as an antioxidant in counteracting free radicals. Therefore, it is important to know the chemical profile and mechanism of action of andrographolide compounds as antioxidants to understand the mechanism of action of these compounds in dealing with various diseases. This study is based on a review of related literature. Based on the literature review, it was found that the mechanism of action of andrographolide as anti-cancer, anti-inflammatory and anti-dyslipidemia is closely related to the mechanism of action of this compound as an antioxidant. The unsaturated γ- lactone structure at C13 and C14 of andrographolide can neutralize superoxide anions. The double bond in this carbonyl ester group will affect the deprotonization of the H atone located at C15 so that the H atoms on C15 will be easily extracted by the highly reactive superoxide anion. Thus, andrographolide can stop the chain reaction of a radical molecule. This mechanism can cause andrographolide compounds to play a role in reducing the effects of free radicals in various diseases.

Verified
Journal Article
Open access
PDF file
EYElvira Yunita
Elvira Yunita
MNMuhammad Luqman Bin Nasaruddin
Muhammad Luqman Bin Nasaruddin
NRNur Zuliani Ramli
Nur Zuliani Ramli
Mohamad Fairuz YahayaMohamad Fairuz Yahaya
Mohamad Fairuz Yahaya
HDHanafi Damanhuri
Hanafi Damanhuri
Tocotrienol-rich fraction (TRF), a subtype of vitamin E, has recently been reported to demonstrate promising neuroprotective properties. However, it remains to be fully determined how it confers protection in the brain. This scoping review aimed to explore and understand the intricate role of TRF in promoting and preserving neuronal well-being. A systematic literature search, based on the framework by Arksey and O’Malley and adhering to the PRISMA-ScR guidelines, was conducted across several databases, including PubMed, Scopus, and Web of Science (WOS), using the following phrases and Boolean operators: (“tocotrienol-rich fraction”) AND ((“neuroprotect”) OR (“cognit”) OR (“brain”)). The search yielded a total of 24 eligible articles, shortlisted based on predetermined inclusion and exclusion criteria established at the outset of the study. The findings highlight a diverse array of TRF-related studies, both in vivo and in vitro, that revealed functional mechanisms through which TRF confers neuroprotection. These include, but are not limited to, antioxidant and anti-inflammatory effects via attenuation of superoxide dismutase (SOD) activity and pro-inflammatory mediators; regulation of metabolic pathways; regulation of neuronal genes, proteins, and maintenance of cellular functions; and subsequent improvements in memory and cognitive performance in animal models following TRF treatment. The convergence of these neuroprotective effects suggests that TRF holds potential as a supplement to support healthy ageing or, at the very least, slow neurodegeneration by mitigating pathological changes that often begin insidiously before the onset of symptoms associated with cognitive decline.

4 May 2023 in Sang Pencerah: Jurnal Ilmiah Universitas Muhammadiyah Buton
Verified
Journal Article
Open access
PDF file
BBBhayu Baruna Bastari
Bhayu Baruna Bastari
EYElvira Yunita
Elvira Yunita
KSKartika Sari
Kartika Sari
MAMarisadonna Asteria
Marisadonna Asteria
JFJulian Famil
Julian Famil
OOOktoviani Oktoviani
Oktoviani Oktoviani
Effective treatment is needed in accelerating the healing process of burn. Propolis extract is a bee product that has a high flavonoid content. Propolis extract is thought to stimulate the process of re-epithelialization of the epidermis. This research was an experimental study with a post-test only control group design. This study used experimental animal, male mice (Mus musculus) Swiss webster strain. Mice were grouped randomly into a control group and a treatment group. Each mouse was given treatment in the form of burn on the back. The control group was the group that was not given propolis or bioplacenton extract. The treatment group was given 5%, 10%, and bioplacenton propolis extract, respectively. Skin histopathological tissue collection was carried out on day 1, day 4, and day 21 to observe the process of re-epithelialization of the epidermis. The results showed that the means of epithelial thickness in the control group and the 5% and 10% propolis extract treatment were significantly thicker on the 21st day of observation when compared to the control group. The administration of bioplacenton showed an increase in the re-epithelialization process of the epidermis on the 4th day. The administration of 10% propolis extract was better in increasing the mean epithelial thickness on the 4th day than the group given 5% propolis extract and bioplacenton.

26 June 2022 in Biodiversitas Journal of Biological Diversity
Verified
Journal Article
Open access
PDF file
EYElvira Yunita
Elvira Yunita
TKTri Kurniati
Tri Kurniati
FRFeby Lilia Rosa
Feby Lilia Rosa
PMPutjha Melati
Putjha Melati
NLNovriantika Lestari
Novriantika Lestari
Yunita E, Kurniati T, Rosa FL, Melati P, LestariN. 2022. Short Communication: Analysis of detected metabolites compounds from the crude extract of Rimau Gerga Lebong orangesfruit (Citrus reticulata ‘RGL’) using LC-QTOF-MS/MS. Biodiversitas 23: 3778-3783. Rimau Gerga Lebong (RGL) oranges are the leading commodity in Bengkulu Province. However, the content of bioactive compounds in RGL oranges has not been widely reported. This study aims to identify the flavonoid, alkaloids, and tannins from the ethanol extract of RGL oranges. The results of further identification will be used as a reference in further research on molecular docking in various biological activities. Chemical compounds were identified using qualitative tandem liquid chromatography quadrupole time of flight mass spectrometry (LC-QTOF-MS/MS). The measurement of vitamin C levels was carried out using High-Performance Liquid Chromatography (HPLC). The results showed 25 identified compounds, consisting of 6 compounds belonging to the alkaloid group, 17 from the flavonoid group, and 2 from the tannin group. The alkaloid group compounds were 2?, 3?, 6exo-trihydroxy nortopane, 2?, 3?-dihydroxy nortopane, isosalsolin,3?-dihydrocadambine, chelidimerine, and oleracein D. The compounds from identified flavonoid group were chebuloside, neokurarinol, rutinoside, flavonone, glucoside, licochalcone, viscumneoside, and pinnatifinoside. The identified tannins are corilagin and moracin. These compounds that have been identified have biological activity potential as antioxidants, anti-asthma, anti-dementia, and anticancer. The vitamin C content of the ethanol extract of RGL oranges was 0.02±0.0001%. This vitamin C supports the antioxidant activity of RGL orange.

5 September 2022 in Bali Medical Journal
Verified
Journal Article
Open access
PDF file
APAhmad Rafi Satrio Prayogo
Ahmad Rafi Satrio Prayogo
EYElvira Yunita
Elvira Yunita
RYRachmawaddah Yolanda
Rachmawaddah Yolanda
IFIsmir Fahri
Ismir Fahri
NLNovriantika Lestari
Novriantika Lestari
EDEllen Maidia Djatmiko
Ellen Maidia Djatmiko
Introduction: Carotid intima-media thickness (CIMT) is a predictor marker of subclinical atherosclerosis that can be measured by ultrasound technique. The clinical symptoms of atherosclerosis usually begin with the thickening of the carotid artery walls. Polymorphism in Apolipoprotein E4 (APO-E4) is considered to be an important genetic determinant of atherosclerosis and Coronary Artery Disease (CAD). The genetic role of APO-E4 on plasma lipid has shown that the APO-E4 allele is associated with increased plasma LDL and total lipid concentration. The main objectives of this study were to identify genotype polymorphisms of the APO-E gene and measure the thickness of the carotid intima in subjects with APO-E4 polymorphisms in the first descendant of coronary heart patients. Patients and methods: A cross-sectional study design was used to determine the polymorphism of the APO-E4 genotype in the first descendant of CAD and non-CAD groups. There were 21 samples in each group. Gene polymorphism examination was carried out by PCR and the CIMT was measured with doppler ultrasound. Results: The result showed that 21.4% of subjects had polymorphism of the APO-E4 genotype with a significant difference between CHD and non-CHD group. This data shows that the APO-E4 genotype is more dominant in the first descendant of patients with CHD when compared to non-CHD parents. The mean values of CIMT ini right and left-sided carotid arteries among APO-E4 genotype and non-APO-E4 genotype were 0.4743 mm vs. 0.4195 mm and bivariate analysis showed a significant difference with a P-value of 0.017. This shows that there is a significant difference in the thickness of the carotid intima in the first descendant of subjects who have the APO-E4 genotype and those who do not. Conclusion: The APO-E4 gene polymorphism was more dominant in the first descendant of CAD patients with a higher CIMT mean value.